Kuznetsova V - Search Results

1

β-d-N⁴-Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome.

Urakova N, Kuznetsova V, Crossman DK, Sokratian A, Guthrie DB, Kolykhalov AA, Lockwood MA, Natchus MG, Crowley MR, Painter GR, Frolova EI, Frolov I. Urakova N, et al. Among authors: kuznetsova v. J Virol. 2018 Jan 17;92(3):e01965-17. doi: 10.1128/JVI.01965-17. Print 2018 Feb 1. J Virol. 2018. PMID: 29167335 Free PMC article.

2

C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions.

Jimenez RV, Kuznetsova V, Connelly AN, Hel Z, Szalai AJ. Jimenez RV, et al. Among authors: kuznetsova v. Front Immunol. 2019 Sep 18;10:2183. doi: 10.3389/fimmu.2019.02183. eCollection 2019. Front Immunol. 2019. PMID: 31620123 Free PMC article.

3

Optimization of methods for the accurate characterization of whole blood neutrophils.

Connelly AN, Huijbregts RPH, Pal HC, Kuznetsova V, Davis MD, Ong KL, Fay CX, Greene ME, Overton ET, Hel Z. Connelly AN, et al. Among authors: kuznetsova v. Sci Rep. 2022 Mar 7;12(1):3667. doi: 10.1038/s41598-022-07455-2. Sci Rep. 2022. PMID: 35256648 Free PMC article.

4

Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies.

Camacho V, Kuznetsova V, Welner RS. Camacho V, et al. Among authors: kuznetsova v. Front Immunol. 2021 Nov 3;12:772408. doi: 10.3389/fimmu.2021.772408. eCollection 2021. Front Immunol. 2021. PMID: 34804065 Free PMC article. Review.

5

Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells.

Patel SB, Kuznetsova V, Matkins VR, Franceski AM, Bassal MA, Welner RS. Patel SB, et al. Among authors: kuznetsova v. Exp Hematol. 2022 Nov;115:1-13. doi: 10.1016/j.exphem.2022.09.001. Epub 2022 Sep 15. Exp Hematol. 2022. PMID: 36115580 Free article.

6

Metabolic alterations mediated by STAT3 promotes drug persistence in CML.

Patel SB, Nemkov T, Stefanoni D, Benavides GA, Bassal MA, Crown BL, Matkins VR, Camacho V, Kuznetsova V, Hoang AT, Tenen DE, Wolock SL, Park J, Ying L, Yue Z, Chen JY, Yang H, Tenen DG, Ferrell PB, Lu R, Darley-Usmar V, D'Alessandro A, Bhatia R, Welner RS. Patel SB, et al. Among authors: kuznetsova v. Leukemia. 2021 Dec;35(12):3371-3382. doi: 10.1038/s41375-021-01315-0. Epub 2021 Jun 12. Leukemia. 2021. PMID: 34120146 Free PMC article.

7

[CAR T-cell therapy: Balance of efficacy and safety].

Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AA. Kulemzin SV, et al. Among authors: kuznetsova vv. Mol Biol (Mosk). 2017 Mar-Apr;51(2):274-287. doi: 10.7868/S0026898417020148. Mol Biol (Mosk). 2017. PMID: 28537234 Free article. Review. Russian.

8

VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells.

Kulemzin SV, Gorchakov AA, Chikaev AN, Kuznetsova VV, Volkova OY, Matvienko DA, Petukhov AV, Zaritskey AY, Taranin AV. Kulemzin SV, et al. Among authors: kuznetsova vv. Oncotarget. 2018 Jan 9;9(10):9021-9029. doi: 10.18632/oncotarget.24078. eCollection 2018 Feb 6. Oncotarget. 2018. PMID: 29507671 Free PMC article.

9

Engineering Chimeric Antigen Receptors.

Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AA. Kulemzin SV, et al. Among authors: kuznetsova vv. Acta Naturae. 2017 Jan-Mar;9(1):6-14. Acta Naturae. 2017. PMID: 28461969 Free PMC article.

10

Chiroptically active quantum nanonails.

Purcell-Milton F, Kuznetsova VA, Bai X, Coogan Á, Martínez-Carmona M, Garcia JA, Bradley AL, Gun'ko YK. Purcell-Milton F, et al. Among authors: kuznetsova va. Nanoscale Horiz. 2024 May 29;9(6):1013-1022. doi: 10.1039/d4nh00015c. Nanoscale Horiz. 2024. PMID: 38597212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page